We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
MAYNE PHARMA (Mayne Pharma International Pty Ltd)
Product name
MAYNE PHARMA
Date registered
Evaluation commenced
Decision date
Approval time
121 (255 working days)
Active ingredients
fluorouracil
Registration type
New generic medicine
Indication
Solar and senile keratoses, Bowen's disease.